The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


VASTAREL 35mg Modified-Release Tablets

35 milligram(s) Modified-release tablet

Les Laboratoires ServierPA0568/033/002

Main Information

Trade NameVASTAREL 35mg Modified-Release Tablets
Active SubstancesTRIMETAZIDINE DIHYDROCHLORIDE
Strength35 milligram(s)
Dosage FormModified-release tablet
Licence HolderLes Laboratoires Servier
Licence NumberPA0568/033/002

Group Information

ATC CodeC01EB Other cardiac preparations
C01EB15 trimetazidine

Status

Authorised/WithdrawnAuthorised
Licence Issued04/11/2005
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back